publicações selecionadas
- Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination
- Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Natural Hallucinogens in Mental Health
- Polypharmacology or ¿Pharmacological Promiscuity¿ In Psychedelic Research: What Are We Missing?
- The effects of Cannabidiol (CBD) and Delta-9-Tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: A systematic review of randomized controlled trials
- Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder
- Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016-2020) systematic review of preclinical and human studies
- Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic
- The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials
- Neural Network Modulation of Ayahuasca: A Systematic Review of Human Studies
- Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy
- Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers
- Acute psychological adverse reactions in first-time ritual ayahuasca users: A prospective case series
- Essential oil-based dispersive liquid-liquid microextraction for the determination of N,N-dimethyltryptamine and β-carbolines in human plasma: a novel solvent-free alternative
- Avaluació de l?estat de salut, els patrons de consum i els beneficis subjectius del cànnabis medicinal en una mostra de pacients catalans amb malalties cròniques
- Ayahuasca: physiological and subjective effects, comparison with d-amphetamine, and repeated dose assessment
- The Adverse Events of Ibogaine in Humans: An Updated Systematic Review of the Literature (2015-2020)
- Ayahuasca and Public Health II: Health Status in a Large Sample of Ayahuasca-Ceremony Participants in the Netherlands
- Hallucinations and Hallucinogens: Psychopathology or Wisdom?
- Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic
- Classical Hallucinogens As Antidepressant Drugs: A Cautionary Approach
- Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects
- The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
- Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020-2022)
- Efeitos da ingestão de ayahuasca em estados psicométricos relacionados ao pânico, ansiedade e depressão em membros do culto do Santo Daime
- Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12-Month Longitudinal Study
- Underground ibogaine use for the treatment of substance use disorders: A qualitative analysis of subjective experiences
- Unveiling ayahuasca psychopharmacology: the accomplishments of Jordi Riba (1968-2020)
- Ayahuasca, an ancient substance with traditional and contemporary use in neuropsychiatry and neuroscience
- Current Evidence of Cannabidiol?s Potential as an Anxiolytic Agent
- Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers
- Cross-cultural adaptation of the City Birth Trauma Scale for the Brazilian context
- Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies
- Molecular level pathways of the therapeutic effects of ayahuasca, a botanical hallucinogen and potential rapid-acting antidepressant
- Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples
- Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
- Adverse Effects After Ayahuasca Administration in the Clinical Setting
- Multifaceted Empathy Test (MET): Validity evidence for the Brazilian population concerning the computer-based (face-to-face) and online versions
- Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study
- Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
- Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action
- Cross-cultural adaptation of the Internet Gaming Disorder Scale - Short Form (IGDS9-SF) to the Brazilian context
- Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial
- Tripping to Cope: Coping Strategies and Use of Hallucinogens during the COVID-19 Pandemic in Three Cultural Contexts
- Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trials
- Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers
- Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability
